OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy
Hanhee Cho, Man Kyu Shim, Yujeong Moon, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2131-2131
Open Access | Times Cited: 9
Hanhee Cho, Man Kyu Shim, Yujeong Moon, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2131-2131
Open Access | Times Cited: 9
Showing 9 citing articles:
Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy
Weixin Zhou, Yujie Jia, Yani Liu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2346-2346
Open Access | Times Cited: 40
Weixin Zhou, Yujie Jia, Yani Liu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2346-2346
Open Access | Times Cited: 40
Stimuli‐responsive linkers and their application in molecular imaging
Jing Wang, Meng Liu, Xinyue Zhang, et al.
Exploration (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 11
Jing Wang, Meng Liu, Xinyue Zhang, et al.
Exploration (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 11
Brentuximab vedotin resistance in classic Hodgkin's lymphoma and its therapeutic strategies: a review
Dayeeta Bera, Dattatreya Roy
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Dayeeta Bera, Dattatreya Roy
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
An Affibody-Cytotoxin Conjugate-Based Nanoagent for EGFR Targeting and Precise Therapy of Epidermal Squamous Cell Carcinoma
Xiaoyuan Yang, Xuelin Xia, Qingrong Li, et al.
ACS Applied Nano Materials (2025)
Closed Access
Xiaoyuan Yang, Xuelin Xia, Qingrong Li, et al.
ACS Applied Nano Materials (2025)
Closed Access
Antibody–Drug Conjugates Targeting CD30 in T-Cell Lymphomas: Clinical Progression and Mechanism
Yi Jiang, Sai Dong, Yang Wang
Cancers (2025) Vol. 17, Iss. 3, pp. 496-496
Open Access
Yi Jiang, Sai Dong, Yang Wang
Cancers (2025) Vol. 17, Iss. 3, pp. 496-496
Open Access
Advances in targeted therapy for pancreatic cancer
Lin Xing, Linlin Lv, Jiaqi Ren, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115717-115717
Open Access | Times Cited: 12
Lin Xing, Linlin Lv, Jiaqi Ren, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115717-115717
Open Access | Times Cited: 12
Nano-Delivery of Immunogenic Cell Death Inducers and Immune Checkpoint Blockade Agents: Single-Nanostructure Strategies for Enhancing Immunotherapy
Yujeong Moon, Hanhee Cho, Kwangmeyung Kim
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 795-795
Open Access | Times Cited: 4
Yujeong Moon, Hanhee Cho, Kwangmeyung Kim
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 795-795
Open Access | Times Cited: 4
Development of a Peptide-Based Nano-Sized Cathepsin B Inhibitor for Anticancer Therapy
So-Hyeon Park, Jun Hyuck Lee, Seong-Bin Yang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1131-1131
Open Access | Times Cited: 5
So-Hyeon Park, Jun Hyuck Lee, Seong-Bin Yang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1131-1131
Open Access | Times Cited: 5
Blue marine therapy: Sea as a trove of natural anticancer drugs
Delphine Bettio, Guylène Page, Vincent Thoreau
Annales Pharmaceutiques Françaises (2023) Vol. 81, Iss. 6, pp. 935-941
Closed Access | Times Cited: 2
Delphine Bettio, Guylène Page, Vincent Thoreau
Annales Pharmaceutiques Françaises (2023) Vol. 81, Iss. 6, pp. 935-941
Closed Access | Times Cited: 2
